The single-pill combination or hybrid therapy in prevention of cardiovascular risk. Case reports
Medycyna Faktów · 2021
DOI: 10.24292/01.mf.0121.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medycyna Faktów, 2021. Verfasst von Celina Wojciechowska.
Abstract (Originalsprache)
In polish population many patients with comorbid hypertension and hypercholesterolemia present low compliance and adherence to medical advising. The achievement of therapeutic goals of blood pressure control and hypercholesterolemia control was about 5,4% in WOBASZ II study. The therapy with antihypertensive drugs and statin in a single-pill combination (SPC) has recently been strengthened in the European and Polish guidelines for the treatment of arterial hypertension and hypercholesterolemia. It seems that therapy induction with SPC by reducing the number of pills to be taken daily could contribute to solve the problem of not undertaking or discontinuing treatment. The combination product present in different doses give possibility of optimization treatment. The use SCP on a larger scale could improve blood pressure control and cholesterol concentration reduction and prevent many of cardiovascular events.
Zitieren
APA
Wojciechowska, C. (2021). The single-pill combination or hybrid therapy in prevention of cardiovascular risk. Case reports. Medycyna Faktów. https://doi.org/10.24292/01.mf.0121.16
Vancouver
Wojciechowska C. The single-pill combination or hybrid therapy in prevention of cardiovascular risk. Case reports. Medycyna Faktów. 2021. doi:10.24292/01.mf.0121.16
BibTeX
@article{Wojciechowska2021,
author = {Wojciechowska, Celina},
title = {The single-pill combination or hybrid therapy in prevention of cardiovascular risk. Case reports},
journal = {Medycyna Faktów},
year = {2021},
doi = {10.24292/01.mf.0121.16}
}
EUVIMED